Enact Holdings, Inc. (ACT) Stock Price & How to Invest

Last updated November 2026

Short answer

ACT is Enact Holdings, the private mortgage insurer spun out of Genworth in 2021, which insures lenders against default on low-down-payment conventional US mortgages. It is a real, cash-generating financial with roughly $1.25B of trailing revenue and about $683M of net income, so the question is less whether the business works and more what a single-product housing-credit insurer is worth at a high single-digit earnings multiple (about 9.8x trailing at ~$46.21 on October 16, 2026).

ACT stock price

As of 2026-11-16, Enact Holdings, Inc. (ACT) last closed at $45.75, up 24.0% over the past year. Over the past 52 weeks it has traded between $36.90 and $50.07.

ACT last close
$45.75
1 day
+0.79%
1 month
-1.15%
1 year
+23.98%
52-week range
$36.90 to $50.07
Last close
2026-11-16

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Enact Holdings, Inc.'s investor relations page. Walnut is informational, not investment advice.

ACT key stats

At $45.75 on November 16, 2026, Enact Holdings, Inc. (ACT) has a market cap of $6.1B, a P/E of 9.6 on trailing earnings (9.1 on forward earnings) and a dividend yield of 2.10%.

Market cap
$6.1B
P/E (trailing)
9.6
P/E (forward)
9.1
EPS (trailing 12 months)
$4.79
Price to book
1.2
Dividend yield
2.10%
Beta
0.44

Market cap, P/E and yield are measured at the $45.75 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Enact Holdings, Inc. (ACT)?

The last two weeks for Enact Holdings, Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • ACT closed at $45.75 on November 16, 2026, down 2.1% over the past five trading days (from $46.71).
  • On November 5, 2026, Enact Holdings, Inc. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 4, 2026, Enact Holdings, Inc. filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 7, 2026, JP Morgan raised its target to $45.00 from $44.00 (Underweight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Enact Holdings, Inc. (ACT) latest quarter

Enact reported revenue of $313 million for Q3 2026, flat from a year earlier (Enact, Nov 4, 2026).

Revenue
$313 million
flat from a year earlier
Diluted EPS (GAAP)
$1.15
up 5% from a year earlier
Premiums
$242 million
down 1% from a year earlier

Source: Enact Q3 2026 results, Nov 4, 2026. Full earnings breakdown

What does Enact Holdings, Inc. (ACT) do?

Enact Holdings (Nasdaq: ACT) sells private mortgage insurance. When a borrower puts down less than 20% on a conventional loan sold to Fannie Mae or Freddie Mac, the GSEs require credit enhancement, and Enact is one of a handful of companies that provides it. The economics are simple to describe and slow to unwind: Enact writes a policy, collects a recurring premium for as long as the loan stays outstanding, and pays a claim only if the borrower defaults and the foreclosure proceeds fall short. That produces a large, slow-moving book. Primary insurance in force was about $274B as of the second quarter of 2026, up roughly 2% year over year, and new insurance written in the quarter was about $15.2B. Revenue is net premiums earned plus investment income on the reserve portfolio, and because the cost base is thin, the operating margin runs above 70%.

The recent results reflect a benign credit environment more than a growth story. Second-quarter 2026 revenue was about $317M with net income near $175M, or about $1.25 per diluted share (adjusted EPS of ~$1.26 against a ~$1.19 consensus), and return on equity around 13%. Persistency has stayed high because borrowers holding low-rate mortgages have little reason to refinance, which keeps premium-paying policies on the books longer than the historical norm. Capital is abundant: PMIERs sufficiency was roughly 161%, about $1.9B above the required level, and management has pointed to $550M to $600M of total capital return for full-year 2026 through buybacks and the $0.24 quarterly dividend. Share count is down roughly 6% year over year. One structural feature dominates the shareholder register: Genworth Financial still owns about 81% of Enact, so the public float is small and Genworth's own capital needs influence how much cash Enact sends out.

The stock closed at ~$46.21 on October 16, 2026, up ~17% year to date and ~32% over one year, for a market value of about $6.4 billion. It slipped after JPMorgan downgraded it to Underweight from Neutral on October 12, and mortgage insurers as a group traded down in early October. On October 1 Enact also added a forward quota share reinsurance transaction to its credit risk transfer program, and AM Best affirmed the ratings of Enact Re on October 2. Third-quarter results are due November 4, 2026, with the earnings call on November 5 and consensus near ~$1.20 EPS on ~$318 million of revenue.

What's driving Enact Holdings, Inc. (ACT)?

1. Insurance in force compounding on high persistency

Earned premium is a function of how much insurance stays on the books, not how much is written in any single quarter. With a large share of outstanding mortgages carrying rates well below current market levels, refinancing is unattractive and policies persist, which lets in-force grow even when origination volumes are soft. That dynamic reverses if mortgage rates fall meaningfully, since a refinancing wave cancels existing policies and forces Enact to rewrite the book at prevailing prices.

2. Credit performance and reserve development

A meaningful slice of reported earnings in recent years has come from favorable reserve development, meaning delinquencies that Enact reserved against cured rather than went to claim. Home price appreciation is the mechanism: a borrower with equity sells rather than defaults. This is a real economic result but it is not the same as underwriting growth, and it is the line item most likely to swing if home prices flatten and unemployment rises.

3. Excess capital and the return program

PMIERs sufficiency around 161% and roughly $1.9B of capital above the compliance requirement give Enact room to fund buybacks and dividends without straining the regulatory position. Shares outstanding fell about 6% over the past year and the payout ratio sits near 18%, so the dividend is well covered. The pace of return is partly a Genworth decision given the 81% stake, which is a governance consideration as much as a capital one.

4. Reinsurance and risk transfer

Enact cedes a portion of its risk through quota-share treaties, excess-of-loss coverage and insurance-linked notes, and runs a Bermuda subsidiary, Enact Re, that assumes third-party mortgage credit risk. Ceding lowers required capital and smooths tail exposure at the cost of giving up premium. The availability and price of that reinsurance capacity is an external variable Enact does not control, and it tightens exactly when mortgage credit looks worst. Enact added to that program on October 1, 2026 with a forward quota share reinsurance transaction, and AM Best affirmed Enact Re's credit ratings the following day.

What are the risks to Enact Holdings, Inc. (ACT)?

Enact is a concentrated bet on US mortgage credit, with essentially one product, one country and one collateral type. A housing downturn combined with rising unemployment would raise delinquencies, turn favorable reserve development into reserve strengthening, and hit earnings faster than premiums could reprice. Policy risk is real and recurring: FHFA capital rules (PMIERs), GSE pricing through loan-level adjustments, and FHA premium changes can each shift the economics of private mortgage insurance without any change in Enact's own execution, since FHA is a direct substitute for the same borrower. Competition among the six private mortgage insurers runs through proprietary risk-based pricing engines that are not publicly disclosed, so price competition is difficult for outside investors to observe until it shows up in returns. Genworth's roughly 81% ownership means the public float is limited, minority holders have little influence, and Enact's capital return policy is shaped by a parent with its own funding needs including its CareScout long-term care initiatives. Analyst sentiment has cooled: JPMorgan moved the stock to Underweight in October 2026 and the five analysts tracked by Yahoo Finance had a hold consensus with a mean target of ~$49.40, while consensus EPS growth slows to ~3.7% in 2027. As of August 2026 no securities-fraud class action against Enact was identified in public filings or court dockets.

What is the Enact Holdings, Inc. (ACT) forecast?

5 analysts publish price targets on ACT, averaging $47.00 as of November 2026, or +2.7% against the $45.75 share price on November 16, 2026. The published targets run from $40.00 to $51.00, a narrow spread, and the ratings split 0 buy, 4 hold, 2 sell. Over the last six months there have been 5 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ACT forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is ACT a buy or a sell?

We give no verdict on Enact Holdings, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Insurance in force compounding on high persistency. Earned premium is a function of how much insurance stays on the books, not how much is written in any single quarter. The most optimistic published target, $51.00, assumes this works close to its best case.

The case against. Enact is a concentrated bet on US mortgage credit, with essentially one product, one country and one collateral type. The most pessimistic target, $40.00, is roughly what ACT is worth if this bites instead.

Read the full bull and bear case on ACT, including what would have to change to break either one. Walnut is not an investment adviser.

Has Enact Holdings, Inc. (ACT) split its stock?

No. Enact Holdings, Inc. (ACT) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Enact Holdings, Inc. (ACT) valued?

Market cap, P/E and dividend yield at today's price are in the ACT key stats above. The business figures below come from Enact Holdings, Inc.'s reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$1.25B (Q2 2026 up ~4% yoy)
  • Net income (TTM): ~$683M (~55% profit margin)
  • Q2 2026 adj. EPS: ~$1.26 (vs ~$1.19 est.)

As of October 2026: At ~$46.21 on October 16, 2026, Enact trades near 9.8x trailing and ~9.2x forward earnings, slightly cheaper than in August after the JPMorgan downgrade, in line with how the market generally capitalizes mortgage insurers because reported profits include reserve releases that are not assumed to repeat through a credit cycle. Price to book near 1.2x with mid-teens ROE implies the market expects returns to normalize lower over time. Because roughly 81% of the shares sit with Genworth, the free float is thin, which affects liquidity and the practical relevance of index-driven flows.

Who competes with Enact Holdings, Inc. (ACT)?

Private mortgage insurers

The direct peer set is small and writes essentially the same product to the same GSE standards: MGIC Investment (MTG), Radian Group (RDN), Essent Group (ESNT), NMI Holdings (NMIH) and Arch Capital's mortgage segment (ACGL). All six compete on proprietary risk-based pricing engines and on lender relationships, which makes market share shifts hard to observe in real time. Enact's differentiators are its Genworth-era lender distribution, its PMIERs capital cushion and Enact Re.

Government mortgage insurance programs

The FHA is the most important non-corporate competitor. A borrower with a modest down payment can take an FHA loan with its own mortgage insurance premium instead of a conventional loan with private MI, and when FHA cuts its premiums, volume migrates out of the private channel directly. VA loans (no mortgage insurance) and USDA programs cover additional slices of the same borrower population.

Capital markets risk transfer

Fannie Mae and Freddie Mac transfer mortgage credit risk to investors through credit risk transfer securities, and global reinsurers assume mortgage risk through quota-share and excess-of-loss treaties. This capital competes with private MI for the same underlying exposure and sets the price at which Enact can offload its own tail risk, so it is both a competitor and a supplier depending on the structure.

What stocks are similar to Enact Holdings, Inc. (ACT)?

Other names that sit close to ACT: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Enact Holdings, Inc. (ACT)

There are three common ways to get ACT exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so ACT sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ACT fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Enact Holdings, Inc. (ACT)

Enact is a profitable, capital-returning mortgage insurer whose earnings are unusually tied to one thing: whether US borrowers keep paying their mortgages. At ~$46 in October 2026, the shares trade near 9x forward earnings and ~1.2x book.

More on Enact Holdings, Inc. (ACT)

Whether ACT is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ACT a buy or a sell?, and where the stock could go from here in the ACT stock forecast.

For income investors, whether ACT pays a dividend and how the payout looks is covered in does ACT pay a dividend? And to weigh ACT against a peer, read the full side-by-side comparisons: ACT vs MTG and ACT vs RDN.

Wondering how ACT fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Enact Holdings, Inc.

Ask Walnut's AI anything about ACT and see how it fits what you own.

FAQ

What does Enact Holdings do?

+

Enact writes private mortgage insurance in the United States. When a borrower makes a down payment below 20% on a conventional loan destined for Fannie Mae or Freddie Mac, the GSEs require credit enhancement, and Enact insures the lender against loss if that borrower defaults. It collects a recurring premium for the life of the policy and pays a claim only when a foreclosure produces a shortfall.

Is ACT the same company as Genworth Mortgage Insurance?

+

Yes, in origin. Enact was Genworth's US mortgage insurance business, rebranded and taken public through an IPO on Nasdaq in September 2021. Genworth Financial (GNW) retained a controlling stake and still owns roughly 81% of Enact as of the second quarter of 2026, so ACT trades with a limited public float and a controlled-company governance structure.

Does ACT stock pay a dividend?

+

Enact pays a quarterly cash dividend, most recently $0.24 per share, which annualizes to about $0.96 and works out to roughly a 2.1% yield at the October 16, 2026 share price of ~$46.21. The payout ratio is around 18% of earnings, and the company returns considerably more capital through buybacks than through the dividend, with shares outstanding down about 6% year over year.

How does Enact make money?

+

Two lines. Net premiums earned on about $274B of primary insurance in force are the main source, and net investment income on the reserve and capital portfolio is the second. Losses and loss adjustment expenses are the offsetting cost, and because administrative expense is small relative to premium, the operating margin runs above 70% in a favorable credit environment.

What happens to Enact if the housing market weakens?

+

Delinquency rates would rise and the reserve releases that have supported recent earnings would likely reverse into reserve strengthening, compressing net income well before premium revenue changes much. The severity of that outcome depends heavily on home prices: a borrower with equity generally sells rather than defaults, so a price decline matters more to claims than a delinquency spike on its own does.

How does Enact compare with MGIC, Radian and Essent?

+

All four write the same GSE-standard product and report similar economics, so comparisons usually turn on capital position, credit mix and how much of the book is reinsured. Enact reported PMIERs sufficiency around 161% in the second quarter of 2026, roughly $1.9B above requirement. The peers price through their own proprietary engines, which are not disclosed, so relative pricing discipline is visible only after the fact in loss ratios.

Why does ACT trade at such a low P/E?

+

Mortgage insurers as a group are capitalized at high single-digit to low double-digit earnings multiples (Enact was near 9.8x trailing in October 2026) because reported profits are cyclical and currently include favorable reserve development that the market does not extrapolate through a downturn. In Enact's case the roughly 81% Genworth stake also limits the float and means minority shareholders have little say in capital allocation, which some investors treat as a discount factor.

How can I invest in Enact Holdings?

+

ACT trades on the Nasdaq and can be bought through any US brokerage that offers listed equities, including brokers connected to Walnut. Anyone sizing a position typically looks at how much housing and mortgage-credit exposure a portfolio already carries through banks, homebuilders or REITs, since those move on many of the same variables. Nothing here is investment advice.

How did Enact do in its latest quarter?

+

In the second quarter of 2026, Enact reported revenue of ~$317 million, up ~4% year over year, and net income of ~$175 million. Adjusted EPS of ~$1.26 beat a ~$1.19 consensus, its fourth straight quarter at or above estimates. Third-quarter results are due November 4, 2026, with consensus near ~$1.20 EPS on ~$318 million of revenue.

How has ACT stock performed in 2026?

+

ACT closed at ~$46.21 on October 16, 2026, up about 16.6% year to date and ~31.9% over one year, within a 52-week range of ~$34.64 to ~$50.56. It fell after JPMorgan downgraded it to Underweight on October 12, 2026, and analysts' mean target was ~$49.40 with a hold consensus.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Enact Holdings, Inc.'s investor relations page or your broker before making investment decisions.